vTv Therapeutics/ US9183852048 /
2024-05-01 9:48:53 PM | Chg. -0.05 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
28.07USD | -0.16% | 41 Turnover: 1,145.65 |
-Bid Size: - | -Ask Size: - | 28.07 | 27.82 |
GlobeNewswire
03-13
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporat...
GlobeNewswire
03-04
vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with ...
GlobeNewswire
03-01
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
GlobeNewswire
02-28
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Inves...
GlobeNewswire
2023-11-09
vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire
2023-11-01
vTv Therapeutics Announces Sale of Shares in Reneo Pharmaceuticals for Proceeds of $4.4 Million
GlobeNewswire
2022-03-23
Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Busin...
GlobeNewswire
2021-12-06
vTv Therapeutics Announces Restructuring to Prioritize its Lead Program and Focus Operations
GlobeNewswire
2021-11-09
vTv Therapeutics Announces 2021 Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire
2021-10-12
vTv Therapeutics Announces Positive Results from Mechanistic Study Indicating No Increased Risk of K...
GlobeNewswire
2021-09-23
vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737,...
GlobeNewswire
2021-08-04
vTv Therapeutics Announces 2021 Second Quarter Financial Results and Provides Corporate Update
GlobeNewswire
2021-06-29
vTv Therapeutics to Participate at the 6th World Psoriasis & Psoriatic Arthritis Conference with Pos...
GlobeNewswire
2021-06-22
vTv Therapeutics and Cantex Pharmaceuticals Announce Strategic Licensing Agreement for Development a...
GlobeNewswire
2021-05-05
vTv Therapeutics Announces 2021 First Quarter Financial Results and Provides Corporate Update
GlobeNewswire
2021-04-13
vTv Therapeutics Receives FDA Breakthrough Therapy Designation for TTP399 for the Treatment of Type ...
GlobeNewswire
2021-04-12
TTP399 SimpliciT-1 Study Results to be presented at a scientific symposium in celebration of the 100...
GlobeNewswire
2021-03-23
vTv Therapeutics Announces Issuance of U.S. Patent Covering Methods of Treatment Using TTP399